Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × abiraterone × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 20 Prostatic Neoplasms, Castration-Resistant 2 Neoplasm Metastasis 2 Bulbo-Spinal Atrophy, X-Linked 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1 Neoplasms 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Melanoma 1 Disease 1 Carcinoma, Small Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bites and Stings 1 Anus Neoplasms 1 Adenocarcinoma 1

Interventions

Bevacizumab 24 atezolizumab 19 durvalumab 18 Specimen Handling 15 pembrolizumab 12 lenvatinib 11 Magnetic Resonance Spectroscopy 11 tremelimumab 10 Nivolumab 10 Sorafenib 8 Radiosurgery 8 Cyclophosphamide 6 camrelizumab 5 apatinib 5 Ipilimumab 5 tislelizumab 4 regorafenib 4 fludarabine 4 cabozantinib 4 X-Rays 4 Immunoglobulin G 4 sintilimab 3 gadolinium ethoxybenzyl DTPA 3 Immune Checkpoint Inhibitors 3 Ethiodized Oil 3 E-7386 3 Disulfides 3 Blood Specimen Collection 3 Biopsy 3 gadobutrol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡